Impact of a Personalized Multicomponent Exercise Program in Real Conditions Among Older Adults With HIV

Quality of Life Clinical Trial

— MOVIhNG  

Official title:

MOVIhNG Study: Impact of a Personalized Multicomponent Exercise Program in Real Conditions on Physical Function, Frailty, and Quality of Life Among Older Adults With HIV

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05435521
• Other study ID #: PI20/01078
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 1, 2021
• Est. completion date: December 31, 2023

Study information

• Verified date: June 2022
• Source: Hospital Universitario Ramon y Cajal
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Longitudinal prospective multicenter study with intervention and control groups and a two-year follow up. Participants will include 40 sedentary adults 50 years old or older with HIV infection and 20 sedentary adults 50 years old or older without HIV infection. Our main objective is to analyze the effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP) on physical function, frailty, and quality of life among older adults with HIV. As secondary objectives, we are going to analyze the effects of a PMEP on body composition, muscle function biomarkers, immunological biomarkers, microbiome, and adherence to PMEP in real conditions under intense, moderate nonexistent monitoring.

Description:

PMEPs will be designed according to the specific characteristics of each participant and their grade of usual physical activity. Physical activity will be registered on physical activity bracelets to get objective information in order to evaluate adherence to the PMEP. A global evaluation of the patients will be made at baseline and months 3, 6, and 12. At each evaluation, samples of blood, stool, urine, and saliva will be taken, and a phone meeting will be scheduled at month 24.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 60
• Est. completion date: December 31, 2023
• Est. primary completion date: October 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years to 120 Years

Eligibility

Inclusion Criteria:

• People living with HIV (Control group not included)
• Age equal or older to 50 years old at initiation of study
• Sedentary individuals: < 150 minutes per week of moderate physical activity.
• Absence of physical limitations which impede the performance of a light or moderate physical activity program

Exclusion Criteria:

• Individuals with one or more of the following diseases:
• Acute myocardial infarction (in the previous 3-6 months) or unstable angina
• Uncontrolled cardiac arrythmias
• Severe aortic stenosis
• Acute Pericarditis/ Endocarditis
• Poorly controlled high blood pressure (> 180/100 mmHg)
• Acute thromboembolic disease
• Acute severe cardiac heart failure

Related Conditions & MeSH terms

• Body Composition
• Frailty
• Physical Inactivity
• Quality of Life

Intervention

Behavioral:
• Personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)
Physical activity expert will design for each participant a personalized exercise program according to baseline situation and previous physical activity. Both will be measured prior to initiation of activity program. Each participant is free to perform physical activity program at his house, outdoor or in a gym as long as it fulfills the prespecified requirements. Exercise programs will be acquired a more personalized shape during the course of the study. In order to motivate participants, personal motivational messages will be sent each week through mail contact or using "WhatsApp" Social Media. Physical activity will be registered in an activity wristband delivered to each participant at baseline evaluation.

Other:
• Body composition
Analyze the effects of PMEP on body composition in each evaluation using an impedance threshold device
• Musculoskeletal and visceral Ultrasound
Quadriceps muscle ultrasound (US) of the rectus femoris measured in each evaluation in order to analyze the effects of PMEP Visceral fat will be analyzed in each visit

Locations

Country	Name	City	State
Spain	Hospital Universitario Infanta Leonor	Madrid
Spain	Hospital Universitario Ramón y Cajal	Madrid

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Universitario Ramon y Cajal	Instituto de Salud Carlos III

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)	To analyze the effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP) on physical function among older adults with HIV.; Physical function will be assessed using Short Physical Performance Battery" (SPPB or Guralnik test) will be measured in each evaluation	12 months
Primary	Effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)	To analyze the effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP) on frailty among older adults with HIV.; Frailty will be assessed using Fried phenotype in each visit	12 months
Primary	Effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP)	To analyze the effects of a personalized multicomponent exercise program (strength, resistance, balance, and flexibility) (PMEP) on quality of life among older adults with HIV.; Quality of life will be assessed using World Health Organization Quality of Life HIV instrument (WHOQOL-HIV-BREF)	12 months
Secondary	Comparison of PMEP effects between HIV and non HIV participants of the same age	In order to measure if the impact of PEMP in older adults with HIV is higher than in non HIV participants, 20 individuals of similar age have been included without HIV infection.; Impact of PMEP will be measured analyzing frailty which will be assessed using Fried phenotype in each visit	12 months
Secondary	Comparison of PMEP effects between HIV and non HIV participants of the same age	In order to measure if the impact of PEMP in older adults with HIV is higher than in non HIV participants, 20 individuals of similar age have been included without HIV infection.; Impact of PMEP will be measured using the Short Physical Performance Battery" (SPPB or Guralnik test) which will be measured in each evaluation	12 months
Secondary	Comparison of PMEP effects between HIV and non HIV participants of the same age	In order to measure if the impact of PEMP in older adults with HIV is higher than in non HIV participants, 20 individuals of similar age have been included without HIV infection.; Impact of PMEP will be measured analyzing body composition (BMI) in kg/m^2 which will be measured in each evaluation in order to assess changes throughout study period	12 months
Secondary	Comparison of PMEP effects between HIV and non HIV participants of the same age	In order to measure if the impact of PEMP in older adults with HIV is higher than in non HIV participants, 20 individuals of similar age have been included without HIV infection.; Impact of PMEP will be measured with Rectus femoris in cm measurements of both legs and visceral fat measurements in cm will be performed using ultrasound in each evaluation in order to see evolution in these parameters	12 months
Secondary	Assesment of body composition evolution after implementation of PMEP using a segmental multi frequency body composition analyser though electrical impedance	Electrical bioimpedance measurement wil be performed in baseline evaluation and 3, 6 and 12 months after initiation of PMEP.; The device used is Tanita MC-780 S MA analyzing BMI in kg/m^2	12 months
Secondary	Effects of PMEP in muscular and immunological biomarkers and in microbiome	At each evaluation (baseline, 3, 6 and 12 months), samples of blood, stool, urine, and saliva will be taken. Immunosenescence and chronic inflammation in HIV are considered at the present moment one of the main drivers of non AIDS comorbidities. Several studies have shown solid conclusions positioning physical activity as a clear intervention which reduces chronic inflammation in individuals without HIV as well as in people living with HIV.	12 months
Secondary	Evaluation of PMEP adherence	PMEP adherence rate will be assessed in real life conditions with different supervision levels (narrow, medium and no supervision at all)	12 months